After the investigators removed Shh-dependent CAFs or α-SMA-positive CAFs using genetic or pharmacological approaches, they consistently found that CAF ablation accelerated tumor progression instead of inhibiting the process. This evidence concerns the gene ACTA1 and neoplasm.